NDC Package 70792-102-30 Tonmya

Cyclobenzaprine Hydrochloride Tablet, Orally Disintegrating Sublingual - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70792-102-30
Package Description:
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
Product Code:
Proprietary Name:
Tonmya
Non-Proprietary Name:
Cyclobenzaprine Hydrochloride
Substance Name:
Cyclobenzaprine Hydrochloride
Usage Information:
TONMYA™ is indicated for treatment of fibromyalgia in adults.
11-Digit NDC Billing Format:
70792010230
NDC to RxNorm Crosswalk:
  • RxCUI: 2723106 - cyclobenzaprine hydrochloride 2.8 MG Sublingual Tablet
  • RxCUI: 2723106 - cyclobenzaprine hydrochloride 2.8 MG (equivalent to cyclobenzaprine 2.47 MG) Sublingual Tablet
  • RxCUI: 2723114 - Tonmya 2.8 MG Sublingual Tablet
  • RxCUI: 2723114 - cyclobenzaprine hydrochloride 2.8 MG Sublingual Tablet [Tonmya]
  • RxCUI: 2723114 - Tonmya 2.8 MG (equivalent to cyclobenzaprine 2.47 MG) Sublingual Tablet
Product Type:
Human Prescription Drug
Labeler Name:
Tonix Medicines, Inc.
Dosage Form:
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route(s):
Sublingual - Administration beneath the tongue.
Sample Package:
Yes
FDA Application Number:
NDA219428
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
08-15-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
70792-102-1414 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
70792-102-6060 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
70792-102-9090 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70792-102-30?

The NDC Packaged Code 70792-102-30 is assigned to a package of 30 tablet, orally disintegrating in 1 bottle of Tonmya, a human prescription drug labeled by Tonix Medicines, Inc.. The product's dosage form is tablet, orally disintegrating and is administered via sublingual form.

Is NDC 70792-102 included in the NDC Directory?

Yes, Tonmya with product code 70792-102 is active and included in the NDC Directory. The product was first marketed by Tonix Medicines, Inc. on August 15, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70792-102-30?

The 11-digit format is 70792010230. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-270792-102-305-4-270792-0102-30